NCT06047184 2023-09-21
Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
BeBetter Med Inc
Phase 1 Unknown
BeBetter Med Inc
Liaoning Cancer Hospital & Institute
Jiangsu HengRui Medicine Co., Ltd.
Haihe Biopharma Co., Ltd.
Institute of Cancer Research, United Kingdom